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ABSTRACT 
 
In advancing discrete-based computational cancer models towards clinical applications, one 
faces the dilemma of how to deal with an ever growing amount of biomedical data that ought 
to be incorporated eventually in one form or another. Model scalability becomes of 
paramount interest. In an effort to start addressing this critical issue, here, we present a novel 
multi-scale and multi-resolution agent-based in silico glioma model. While ‘multi-scale’ 
refers to employing an epidermal growth factor receptor (EGFR)-driven molecular network to 
process cellular phenotypic decisions within the micro-macroscopic environment, ‘multi-
resolution’ is achieved through algorithms that classify cells to either active or inactive spatial 
clusters, which determine the resolution they are simulated at. The aim is to assign 
computational resources where and when they matter most for maintaining or improving the 
predictive power of the algorithm, onto specific tumor areas and at particular times. Using a 
previously described 2D brain tumor model, we have developed four different computational 
methods for achieving the multi-resolution scheme, three of which are designed to 
dynamically train on the high-resolution simulation that serves as control. To quantify the 
algorithms’ performance, we rank them by weighing the distinct computational time savings 
of the simulation runs versus the methods’ ability to accurately reproduce the high-resolution 
results of the control. Finally, to demonstrate the flexibility of the underlying concept, we 
show the added value of combining the two highest-ranked methods. The main finding of this 
work is that by pursuing a multi-resolution approach, one can reduce the computation time of 
a discrete-based model substantially while still maintaining a comparably high predictive 
power. This hints at even more computational savings in the more realistic 3D setting over 
time, and thus appears to outline a possible path to achieve scalability for the all-important 
clinical translation. 
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1. INTRODUCTION 
 
In recent years, cancer modeling has become a rather popular interdisciplinary research topic 
in computational biology. Various approaches have been employed to move towards 
predictive oncology. Currently, such computational approaches include continuum [1-6], 
discrete [7-11] and hybrid models [12-19]. Although ‘continuum’ techniques can describe for 
example the change of cancer cell density [3, 4, 20], the diffusion of chemoattractant [16], 
heat transfer in hyperthermia treatment for skin cancer [21, 22], cell adhesion, and the 
molecular network of a cancer cell [23, 24] as an entire entity using differential equations, 
their ability to investigate single-cell behaviors and cell-cell interactions are very limited. 
Conversely, ‘discrete’ modeling can simulate (for example, via cellular automata [25]) the 
behavior of individual cancer cells as well as cell-cell and cell-extracelluar matrix (ECM) 
interactions [7, 10], but it fails when the inclusion and investigation of most fluid-physical 
aspects relevant to cancer becomes necessary [8]. To overcome the shortcomings of both 
modeling techniques, we employ a particular type of ‘hybrid’ approach, an agent-based 
model. The agent-based approach simulates multi-scale glioma growth and expansion [12-16, 
26], thereby describing cancer as a complex dynamic, adaptive, and self-organizing system 
[27]. The advantage of such a model is that each cell is simulated as an agent equipped with 
an intracellular molecular signaling network that determines its phenotype on the microscopic 
scale [12, 13, 16]. This allows the investigation of the interactions among these cells, the 
interactions between the cells and ECM, as well as the impact of each cell’s intracellular 
signaling dynamics on its spatio-temporal behavior within the micro-macroscopic 
environment. However, multi-scale agent-based modeling requires significant computational 
resources [28], especially when simulating millions of cancer cells within a realistic 
microenvironment. Our previous works [12-17, 29] therefore had to reduce the number of 
cancer cells used in the simulation as well as the ECM volume, thereby slowing the 
translation of this simulation platform into clinical applications. To temporarily resolve this 
scalability problem, one may choose to employ parallel computation [30] in an effort to 
reduce the computational workload for the continuum module. Nonetheless, it will be a 
critical prerequisite for this hybrid platform’s clinical applicability to be efficient in terms of 
computational workload, while still maintaining sufficient predictive power. As a first step, 
here we develop four computational methods to classify cancer cells into either active or 
inactive clusters. In an active cluster, each cell’s molecular profile is monitored (‘high-
resolution’) to determine whether any phenotype switching is being triggered. In an inactive 
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cluster, all cells are considered as an entity without tracking each individual cell’s molecular 
profile (‘low-resolution’). Next, we analyze and compare the computation time and predictive 
power of each method, determine their performance vis-à-vis the high-resolution control, and 
rank them accordingly. Finally, we introduce a combination method (consisting of the two 
computing methods with the highest separate ranking values) to demonstrate the flexibility of 
this multi-resolution approach for future extensions. 
 
 
2. METHODS & TECHNIQUES 
 
To start addressing the issue of scalability in agent-based cancer modeling algorithms [28], 
we present here several distinctively different computational methods designed to reduce the 
workload by utilizing selective spatial resolution, while simultaneously aiming to maintain 
sufficient overall predictive power. In the following sections, we will describe the modeling 
platform first from the multi-resolution perspective, and then subsequently from the multi-
scale perspective. 
 
2.1. Multi-resolution perspective 
 
2.1.1. Lattice setup 
Compared to our previous research [12, 13, 16], the multi-resolution concept is an innovative 
design which is based on two different resolution lattices within the microscopic environment. 
One is a 100x100 low-resolution lattice with a grid size length of approximately 62.5 µm, 
reflecting the smallest unit of a hemocytometer used in comparable in vitro experimental 
setups for counting the number of cells via light microscopy (Figure 1(a)). The other is a 6x6 
high-resolution lattice (superimposed on each of the grid points of the aforementioned low-
resolution lattice) with a grid size of approximately 10 µm, thus reflecting the idealized 
diameter of a cancer cell. We also define that one grid point of the low-resolution lattice can 
contain only one single cell cluster, and that one cancer cell occupies one grid point of the 
high-resolution lattice only. This implies that a cell cluster can consist of 36 cancer cells at 
most, denoted as a dense cluster. With the multi-resolution lattice configuration depicted in 
Figure 1(b), the model can simultaneously simulate the cancer’s progression and invasion at 
two different spatial resolutions: (a) Low resolution: This model visualizes, at any point in 
time, the entire (2D) tumor growth by displaying the behavior of both active and inactive 
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clusters in the microscopic environment. (b) High resolution: In this model, an active cluster 
is considered as a heterogeneous cell cluster in which the cells can possess a migratory, 
proliferative, or quiescent phenotype, while an inactive cluster is considered as a 
homogeneous cell cluster in which all the cells are in a quiescent phenotype. For this reason, 
we only evaluate the molecular network profile in cells that belong to active clusters in an 
effort to reduce the computational workload and to model the cells’ phenotypic fate on the 
high-resolution lattice. The flowchart of the resulting cellular automaton is pictured in Figure 
2. Note that Figure 2 (b) is used to illustrate step 3 of Figure 2 (a) in more detail. 
 
Figure 1 
Figure 2 
 
2.1.2 Computational methods  
We developed four different computational methods to classify the cells into inactive or active 
clusters, and a control to serve as the baseline for comparison. 
 
1. Control: All clusters are set to active so that each cell is tracked by the program; that is, 
each of these cell’s molecular signaling pathway is being simulated at every point in time so 
that the fluctuating concentrations of its (environmentally influenced) sub-cellular signal 
processing components trigger dynamic phenotypic changes throughout the cells. 
 
2. Space method: If all the topographic neighborhoods of a dense cluster are themselves dense, 
then this cluster is deemed inactive; otherwise, it is active. 
 
3. Radius method: At each time step, first the average distance to the center of mass of all 
active clusters is set as the basic radius threshold . We then also calculate the tumor 
progression radius difference between the control tumor and the one generated by this method 
(
bR
control
controlmethod  radius
Radius
RadiusRadiusDIFFRC
−= ) to dynamically adjust the radius threshold with 
.)1( weightDIFFRR RCbA ⋅+⋅=
AR
 Thus, at each time step, if a cluster’s distance to the center-
of-mass is less than , that cluster is set to be inactive. Otherwise, it is deemed active. This 
follows the concept that surface asymmetries must be monitored more closely in a growing 
tumor as they reflect an intrinsic and/or extrinsic heterogeneity with potential implications for 
the overall dynamics. 
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4. Number method: At each time step, all clusters are ranked in a descending ordered list 
according to the distance between each of the clusters and the center of mass of all the clusters. 
First, half of the clusters are set to the basic number threshold . Secondly, we again 
employ the tumor progression radius difference between the control and number method 
(
bN
control
controlmethodnumber 
Radius
RadiusRadiusDIFFNC
−= ) to dynamically adjust the threshold with 
 At each time step, if its number is greater than , the cluster is set 
as an inactive cluster. Otherwise, it is considered to be active. 
).1( NCbA DIFFNN −⋅= AN
 
5. Phenotype method: At each time step for every cluster, first  is set as the basic threshold 
ratio of the sum of migratory and proliferative cells to the total cells in the cluster. We then 
employ the tumor progression radius difference between the control and the phenotype 
method (
bP
control
controlmethod phenotype
Radius
RadiusRadius
DIFFPC
−= ) to dynamically adjust the ratio 
threshold according to  At every time step, if the ratio of the sum of 
the number of migratory and proliferative cells to the total number of cells in the cluster is 
less than , then that cluster is deemed inactive. Otherwise, it is considered to be active.   
).1( NCbA DIFFPP +⋅=
AP
  
2.2. Multi-scale perspective 
 
Here, we introduce briefly how the model simulates both tumor progression and invasion on 
and across multiple scales (for more details, please see [16, 17, 29]). Based on a solid body of 
work implicating its role in tumor progression at the molecular level, each cell is equipped 
with a simplified epidermal growth factor receptor or EGFR pathway (Figure 3). Specifically, 
equations 1-19 in Table 1 (a) are employed to describe the chemical reactions among the 
molecular species in this pathway with Table 1 (b)-(d) listing the corresponding parameter 
values [31]. 
 
Figure 3 
Table 1 
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Based on the proposed dichotomy between the migratory and proliferative phenotypes in 
glioma by Giese et al. [32], and the observation of a transient increase in PLCγ resulting in 
(breast) cancer cell migration by Dittmar et al. [33], we have previously [12, 13, 16] 
hypothesized the following simplified biological switching behavior: if the percent change of 
the glioma cell’s phosphorylated PLCγ concentration exceeds a set change rate threshold of 
the concentration of phosphorylated PLCγ, the cell becomes migratory; otherwise, it adopts a 
proliferative phenotype. Here, we use the average phosphorylated PLCγ concentration 
changes of all the cells as the change rate threshold at each time step. (We note that PLCγ is 
merely meant as a representative example of a presumably much more complicated set of 
molecular switching profiles). 
 
On the micro-macroscopic level, we employ a continuum module to simulate the diffusion of 
the chemical cues glucose (X0) and TGFα (X1) with equations 20 and 21:  
...3,2,1 ,0
20 =∇⋅=∂
∂ tXD
t
X ij
G
ij
                                                                     (20) 
...3,2,1 ,1
21 =∇⋅=∂
∂ tXD
t
X ij
T
ij
                                       (21) 
where is the diffusion coefficient of glucose [34], and TD is the αF  diffusion coefficient 
[35]. Furthermore, we employ a discrete module to simulate the cell’s glucose uptake and 
αTGF  secre n the high-resolution lattice with equations 22 and 23:  
GD  TG
tion o
G
tt UXX −= −100                          (22) 
T
tt SXX += −111                                         (23) 
where t  represents the time step,  is the cell’s glucose uptake coefficient [36], and  is 
the  secretion rate [37]. The diffusions of glucose and   are simulated on the low-
resolution lattice; however, the concentration of  and glucose at each grid point in the 
low-resolution lattice will be randomly distributed on the corresponding high-resolution 
lattice. 
GU TS
αTGF αTGF
αTGF
 
 
3. RESULTS 
 
Our code is written in Microsoft Visual Studio C++. We ran the simulation 10 times with 
varying migration durations (1-5 time steps, one time step being equivalent to one hour) for 
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each computational method. The algorithm requires approximately 1 hour of CPU time on a 
Dell Precision 690 workstation with 64-bit Quad-Core Intel®  Xeon®  5300 series processors.  
 
Microscopic patterns. Figure 4 displays the snapshots of the virtual tumor cells at time steps 
1 and 100 for the control (a) and the four computational methods (b-e), respectively. Here it 
should be noted that since different computational methods employ varying classification 
schemes to separate the cancer cells into either active or inactive clusters, Figure 4 shows 
qualitative differences among these methods at the first time step. At the start, for example, 
the control and phenotype method will classify all the cells into active clusters, whereas the 
number, radius, and space methods will separate the cells into active and inactive clusters.  
 
Figure 4 
 
Performance. Figure 5 (a) displays the computation time required for each multi-resolution 
method, with the control serving as a comparison. While the number method, as already 
qualitatively suggested by Figure 4, indeed requires the minimum computation time, 
unfortunately its resulting tumor radius progression showed the largest deviation from the 
control (Figure 5 (b)), fluctuating considerably and exhibits a substantial average error 
(Figure 5 (c)). Conversely, while the space, radius, and phenotype methods also resulted in 
reduced computation time (Figure 5 (b)), their tumor radii remained very close to the 
control’s (and rather stable throughout), thus yielding a relatively small average error (Figure 
5 (c)). 
 
      Figure 5 
 
Functionality. Figure 6 (a) and (b) describe the number of active and inactive clusters for 
each computational method. As intended, the control only operates with active clusters and 
thus represents the upper limit. Also, Figure 4’s qualitative impression is now quantitatively 
supported, in that the number method indeed utilizes the lowest number of active clusters, and 
the highest number of inactive clusters. The space and radius methods operate with moderate 
numbers of active and inactive clusters. With regards to the phenotype method, we found its 
profile of active and inactive clusters to evolve in a similar fashion to the control during the 
early stages up until time step 50, after which its number of active clusters drops abruptly, and 
the number of inactive clusters increases markedly, subsequently followed by a period of 
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stability. Likewise, Figure 6 (c) and (d) show the number of checked and unchecked cells, 
which parallel the findings on the cluster level.   
 
Figure 6 
 
Ranking. To integrate the findings presented in Figures 4-6 in a quantitative manner, we 
have developed a formula that ranks the overall performance of each computational method 
according to  
 
.100 ,4,3,2,1,100,3,2,1,
*
*
1
==⋅⋅⋅== ∑
=
nji
Timen
TimeDIFF
R
n
i control
ji                                          (24) 
 
where i is the time step from 1 to 100, and j represents the specific computational method 
with (1) being the space method, (2) the radius method, (3) the number method, and (4) the 
phenotype method.  and are the numbers of inactive and active clusters, 
respectively.  is the simulation difference in tumor radius between each computational 
method and the control, represented by 
iInactive iactive
iDIFF
 control
controli
Radius
RadiusRadius
DIFFi
−= . Here, the best 
performing method should use less computation time by operating with a greater number of 
inactive clusters and a lower number of active clusters, while simultaneously only having to 
accept a small difference in the resulting tumor progression radius as compared to the control. 
As listed in Table 2, using this method, the radius method ranks as number one, followed by 
the space and phenotype methods; the number method ranks last. 
 
Table 2 
 
 
4. DISCUSSION & CONCLUSIONS 
 
Mathematical modeling and computational simulations have become increasingly important 
for data integration as well as hypothesis generation in cancer research. Methods used include  
a variety of techniques. For example, Cristini et al. [38] employed a continuum mathematical 
approach to describe microenvironmental substrate gradients that may drive morphologic 
instability in gliomas, while Jain et al. [39] used the same modeling technique to simulate 
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angiogenesis under the control of the VEGF–Bcl-2–CXCL8 pathway. Conversely, Peirce et al. 
[40] employed a discrete method (cellular automaton [25]) to predict micro-vascular network 
patterning by integrating epigenetic stimuli, molecular signals, and cellular behaviors, and 
Stamatakos et al. [11], also using a discrete approach, simulated the glioma cell cycle 
explicitly to predict the response of radiotherapy. In contrast to both approaches, Mansury et 
al. [14, 15], Athale et al. [12, 13] and Zhang et al. [16, 29] all employed a discrete-continuum 
(i.e. hybrid) model to simulate brain cancer progression. From these examples, in addition to 
other works, it still holds that while continuum modeling can appropriately represent tissue 
level properties [38, 41] and cell densities [4, 20, 42, 43], it is impractical to describe single 
entities such as cells, genes, or proteins and their various interactions on the cellular and sub-
cellular level. However, to achieve such resolution with a discrete model requires significant 
computational resources particularly when simulating millions of cells simultaneously. And, 
while hybrid modeling emerges as the most promising avenue in that it is capable of 
simulating both tumor tissue and single cell behavior at the same time, it mandates a reduced 
description of microenvironmental complexity and is bound by the number of simulated cells 
and signaling pathways to remain computationally tractable.   
 
To begin to address the currently limited scalability of such hybrid computational models, we 
have developed a multi-scale, multi-resolution agent-based glioma model that classifies the 
simulated cancer cells into either ‘active’ or ‘inactive’ clusters with several novel 
computational methods, such that it is possible to utilize currently limited computational 
capabilities to simultaneously model millions of cells. As mentioned before in the result 
section, these computational methods are designed with respect to micro-macroscopic 
properties such as peritumoral space, tumor radius, and tumor cluster number, as well as 
cellular properties such as the phenotypes’ sub-cellular signaling networks trigger. The major 
aim of this research has been to demonstrate that these computational methods can reduce the 
computational workload to a certain extent while preserving predictive power. Additionally, 
the simulation results of these computational methods show several interesting findings. First, 
the space and radius methods result in tumor expansion patterns that are qualitatively similar 
to the control, more so than the phenotype and number methods (Figure 4, Figure 5 (b) and 
(c)). Second, comparing the space, radius, number and phenotype methods versus control, we 
found a 9.34%, 1.95%, 36.74% and 7.74% reduction of the necessary computation time, 
respectively. Thus, the number method commands the least computation time (Figure 5 (a)), 
generates fewest active clusters, and checks the fewest cells as compared to the other methods, 
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including the control (Figure 6). Third, the training algorithms are superimposed on these 
computational methods except the space method to enhance the predictive power, but the 
tumor radii from every method is still not able to exactly match that of the control (Figure 5b, 
Figure 7c). While the resulting “average error vs. control” (Figure 5c, Figure 7d) for most of 
the computational methods remain relatively small throughout the length of the simulation, it 
is especially apparent with the number method, exhibiting the weakest predictive power as 
measured by the substantial “average error vs. control” value. Lastly, since there is no optimal 
computational method here that simultaneously yields the least radial deviation from the 
control while also uses the least amount of computation time, we have developed a novel 
formula (equation 24) to integrate considerations from the vantage points of both predictive 
power and computational workload. This equation was then used to rank the efficiencies of all 
the computational methods, with Table 2 showing the following result: the radius method 
tops the performance scale, followed by the space and phenotype methods, and lastly the 
number method.  
 
This ranking result can be explained as follows: For the cellular automaton component of our 
model [15, 16] (Figure 2), a cancer cell will choose an unoccupied lattice site with the highest 
glucose concentration to divide into or move to. Once there are no unoccupied locations in its 
neighborhood, the cell will turn quiescent. Therefore, both the space and radius method save 
computation time by deactivating the tightly packed cells in the center of the tumor. In doing 
so, the radius method is superior to the space method, because deactivating the clusters in the 
boundary of the tumor (space method) will negatively impact the tumor progression radius 
more so than deactivating the clusters in the center of the tumor (radius method). However, 
the classification mechanism of the space and radius methods is different from that of the 
number method. That is, because the shape of the tumor is irregular and the density of the 
clusters is inhomogeneous, the number method will deactivate many cells within the vicinity 
of the tumor boundary, weakening the result by way of a large “average error vs. control” 
(Figure 5 (c), Figure 7 (d)). With regards to the phenotype method, especially at the 
beginning of the simulation, the algorithm must check each cell’s molecular pathway to 
decide if it is an active or an inactive cluster (similar to the process in the control). The cell 
cycle requires several time steps to switch a cell’s phenotype, which (in Figure 6) leads to the 
marked changes around time step 50 and hampers the phenotype method’s capacity to reduce 
the computational workload in the early stages of the simulation. Because there is no ideal 
algorithm, amongst the ones studied, that combines predictive power with low computation 
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time, we presented a new method by integrating the #1 and #2 ranked methods (Table 2) (i.e. 
adding the radius requirement into the space method; the other way around would not 
improve upon the radius method’s singular performance, due to the underlying criteria) in an 
effort to determine if such a combinatorial method would further improve the results, and to 
demonstrate the flexibility and extensibility of this study.  
 
For the combination method, we use the radius method to first classify the cells in the center 
of the tumor into inactive clusters, after which only the clusters in the boundary of the tumor 
are left to be classified by the space method. We hypothesize that this approach reduces 
computation time markedly. And indeed, Figure 7 (a) confirms that the computation time of 
this combination method exhibits a 14.1% reduction versus the control, substantially shorter 
than both the space and radius methods alone due to the generation of a lower number of 
active (and a greater number of inactive) clusters (Figure 7 (b) and Figure 6). However, 
Figure (c) shows also that the error (vs. control) generated by the combination method 
exceeds that resulting from the radius method, but remaining lower than that of the space 
method. This is due to the fact that although employing both radius and space requirements 
can save computation time, the clusters on the boundary of the tumor that are deactivated by 
the space method will still influence the tumor progression curve. Taken together, however, 
our ranking system establishes this combination method as the new optimal performing 
method, even if its rank value of 4.06774 is only a relatively small improvement over the 
radius method alone.  
 
Figure 7 
 
Despite its technical merits, the current approach still has several pitfalls. At this point, 
although the training algorithms of these computational methods can adjust the active/inactive 
cluster number threshold at each time step by the “average error vs. control” (Figure 5 (c)) in 
the previous time step (Section 2.1.2 illustrates this in detail), the cell cycle duration delays 
cell proliferation in the active clusters such that these active clusters cannot have sufficient 
migratory or proliferatory cells in the following step. The result is that the tumor radius never 
really approaches that of the control (Figure 5 (b)), with this error never really becoming 
smaller (Figure 5 (c)). To address these shortcomings in the future, we anticipate that the 
algorithms will have to be trained on other attributes such as topographic surface patterns, the 
tumor cell number, and perhaps signaling pathway profiles that are implicitly related to the 
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cell cycle, alongside the tumor progression radius. This way, the impact of the time delay may 
be reduced.  
  
In summary, our previously developed 2D brain tumor model has been given a novel multi-
resolution design. This allows the incorporation of several computational methods, and thus 
their performance testing, in an effort to reduce the computational workload while still 
maintaining sufficiently high predictive power. The multi-resolution design provides this 2D 
model, which only incorporate roughly 3000 cells over relatively small ECM volumes and 
short simulation durations, with a small advantage. However, a future goal is the prediction of 
actual tumor progression, with a model consisting of millions of cells over much larger ECM 
volumes and longer simulation durations. It is thus reasonable to expect that applying these 
methods to a more clinically-relevant 3D model will save even more computational resources 
over time, which would help in bringing these promising computational approaches ever 
closer to the clinical arena.  
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CAPTIONS 
 
Figure 1: (a) Hemocytometer used in a typical in vitro cell counting experiment, with the 
minimum length of the grid size being 62.5 μm. (b) A schematic of the coupled high- and 
low-resolution lattices. 
 
Figure 2: Algorithm flow charts (a) for classifying the cells into either active or inactive 
clusters on the low-resolution lattice, and (b) for checking each cell’s molecular pathway in 
an active cluster on the high resolution lattice.  
 
Figure 3: The EGFR gene-protein interaction network [17, 31].  
 
Figure 4: Snapshots of the simulation for each computational method at time step 1 (left) and 
100 (right column): (a) control, (b) space method, (c) radius method, (d) number method, and 
(e) phenotype method. Note that black represents active clusters (comprised of proliferative, 
migratory and quiescent cells), and green represents inactive clusters. 
 
Figure 5: Shown are (a) the average computation time of 10 runs with bars representing 
standard deviation, and (b) the simulated tumor radius for the four multi-resolution methods 
and the high-resolution control. The x-axis denotes the time step, and the y-axis represents the 
tumor radius  (in pixels; 1 pixel = 1.47μ.) (c) Average error of the space method, radius 
method, number method, and the phenotype method versus control. The x-axis denotes the 
time step, and the y-axis represents the percent deviation for a particular method from the 
control. 
 
Figure 6: Depicts (a) the number of active multi-cellular clusters, (b) the number of inactive 
multi-cellular clusters, (c) the number of checked cells and (d) the number of unchecked cells. 
(Note: If the program investigates a cell’s molecular pathway, this cell is deemed ‘checked’, 
otherwise it is regarded as ‘unchecked’). 
 
Figure 7: Shown are (a) the average computation times of 10 runs with bars representing the 
standard deviation for the “combination” method, (b) the number of active and inactive multi-
cellular clusters for this method versus control, (c) the simulated tumor radius for the five 
multi-resolution methods including the combination method versus high-resolution control. 
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Here again, the x-axis denotes the time step, and the y-axis represents the tumor radius (in 
pixels; 1 pixel = 1.47μm), and (d) the average error between the space, radius, number, 
phenotype, or combination methods and the control. The x-axis denotes the time step, and the 
y-axis represents the percent deviation for a particular method from the control. 
 
Table 1: (a) Kinetic equations employed to describe the reactions between the EGFR species; 
(b) components of the EGFR gene-protein interaction network; (c) coefficients of the EGFR 
gene-protein interaction network taken from the literature [17, 31]; (d) coefficients of the 
micro-macroscopic environment of the model [16, 17, 28, 36]. 
  
Table 2: The rankings for (1) the radius method, (2) the space method, (3) the phenotype 
method, and (4) the number method, using equation 24. 
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Figure 1 
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Figure 2  
 (a) 
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Figure 3 
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Figure 4 
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Figure 5 
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Figure 6 
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Figure 7 
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TABLES 
Table 1 
(a)  
11 / vdtdX −=        (1) 312111 XkXXkv −−=      (11) 
12 / vdtdX −=             (2) 423322 XkXXkv −−=        (12) 
213 2/ vvdtdX −=         (3) 53433 XkXkv −−=  (13) 
3424 / vvvdtdX −+=   (4) )/( 54544 XKXVv +=        (14) 
54735 / vvvvdtdX −−+=     (5) 756555 XkXXkv −−=         (15) 
586 / vvdtdX −=                  (6) 86766 XkXkv −−=        (16) 
657 / vvdtdX −=          (7) 957877 XXkXkv −−=       (17) 
768 / vvdtdX −=      (8) )/( 98988 XKXVv +=          (18) 
9879 / vvvdtdX −−=      (9) 109999 XkXkv −−=        (19) 
910 / vdtdX =               (10)   
 
(b)  
Symbol Molecular variables Initial values  
0X  Glucose 25 mM 
1X  TGFα 9010.55 nM 
2X  EGFR 100 nM 
3X  TGFα –EGFR 0 nM 
4X  (TGFα –EGFR) 2 0 nM 
5X  TGFα –EGFR-P 0 nM 
6X  PLCγ 10 nM 
7X  TGFα –EGFR-PLCγ 0 nM 
8X  TGFα –EGFR-PLCγ-P 0 nM 
9X  PLCγ-P 0 nM 
10X  PLCγ-P-I 0 nM 
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(c)  
ard rate (s-1) Reverse rate (s-1) Michaelis constants (nM) Maximal enzyme Forw
rates (nM s-1) 
003.01 =k  06.01 =−k  504 =K  4504 =V  
01.02 =k   1.02 =−k  1008 =K  18 =V  
13 =k     01.03 =−k  
0. 605 =k  2.05 =−k    
16 =k  05.06 =−k    
3.07 =k  006.07 =−k    
19 =k  03.09 =−k    
 
) 
fficient Value Units Description 
(d
Coe
GD  
7−
 107.6 × 1  2 −scm Glucose diffusion coefficient 
TD  
71018.5 −×  12 −scm  TGFα diffusion coefficient 
TS  0.2 
1−nMh  TGFα secretion rate 
GU  
1210−×  7.7 mol/h.cell Glucose uptake rate 
 
able 2 
ethod Rank Ranking value 
 
T
 
M
Radius 1 4.068785 
Space 2 5.139941 
Phenotype 3 5.223518 
Number 4 7.710731 
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